Factor XI inhibitors show promise as a safer alternative to direct oral anticoagulants for preventing and treating thrombosis, offering similar efficacy with reduced bleeding risk.
Jonathan Arnon, PharmD
Advertisement
Articles by Jonathan Arnon, PharmD
Advertisement
Latest Updated Articles
Factor XI Inhibitors: The Future of AnticoagulationPublished: March 18th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
2
Five-Year NATALEE Data Show Ribociclib Improves Outcomes in High-Risk HR+/HER2– Early Breast Cancer
3
Under Pressure: A Brief Overview of the Updated Hypertension Guidelines
4
Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer
5
